Global Immunotherapy Drugs Market, By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Interferons & Interleukins), Therapeutic Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), End User (Hospitals, Clinics), and Region — Industry Analysis and Forecast to 2030
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Architecture
2.3 Scope of the Study
2.4 Related Stakeholders
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.2.1 Key Insights
3.2.2 Breakdown of Primary Interviews
3.3 Secondary Research
3.3.1 Important Sources
3.4 Market Size Estimation Approaches
3.4.1 Top-Down Approach
3.4.2 Bottom-Up Approach
3.4.3 Data Triangulation
3.5 List of Assumptions
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Opportunities
4.5 Challenges
4.6 Porter’s Five Forces Model Analysis
4.7 Value Chain Analysis
4.8 Regulatory Landscape
5 Global Immunotherapy Drugs Market: Type
5.1 Introduction
5.2 Monoclonal Antibodies
5.3 Checkpoint Inhibitors
5.4 Interferons & Interleukins
5.5 Other Immunotherapies
6 Global Immunotherapy Drugs Market: Therapeutic Area
6.1 Introduction
6.2 Cancer
6.2.1 Malignant Cancers
6.2.2 Benign Cancers
6.3 Autoimmune & Inflammatory Diseases
6.4 Infectious Diseases
6.5 Other Therapeutic Areas
7 Global Immunotherapy Drugs Market: End User
7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.4 Other End Users
8 Global Immunotherapy Drugs Market: Regional Trends
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 South Korea
8.4.5 Rest of Asia-Pacific
8.5 Middle East and Africa
8.5.1 GCC Countries
8.5.2 South Africa
8.5.3 Rest of Middle East and Africa
8.6 Latin America
8.6.1 Brazil
8.6.2 Mexico
8.6.3 Argentina
8.6.4 Rest of Latin America
9 Competitive Landscape
9.1 Introduction
9.2 Vendor Evaluation Criteria
9.3 Vendor Share Analysis, 2023
9.4 Recent Developments, 2021-2023
9.4.1 New Product Launches
9.4.2 Partnerships
9.4.3 Mergers or Acquisitions
9.4.4 Business Expansions
10 Company Profiles
10.1 F. Hoffmann-La Roche Ltd
10.2 Pfizer Inc.
10.3 Merck & Co., Inc.
10.4 Johnson & Johnson
10.5 Novartis International AG
10.6 Sanofi
10.7 GSK plc.
10.8 Abbvie
10.9 Boehringer Ingelheim
10.10 AstraZeneca
10.11 Amgen
10.12 Eli Lilly and Company
10.13 Genmab
10.14 Immatics Biotechnologies GmbH
10.15 Gilead Sciences
10.16 NBE Therapeutics
10.17 BioNTECH SE
10.18 Teva Pharmaceuticals
11 Appendix
11.1 Discussion Guide
11.2 Customization Options
11.3 Related Reports
List of Tables
Table 1 Global Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 2 Global Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 3 Global Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 4 Global Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 5 Global Immunotherapy Drugs Market, By Region, 2023-2030 (USD Billion)
Table 6 North America Immunotherapy Drugs Market, By Country, 2023-2030 (USD Billion)
Table 7 North America Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 8 North America Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 9 North America Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 10 North America Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 11 US Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 12 US Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 13 US Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 14 US Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 15 Canada Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 16 Canada Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 17 Canada Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 18 Canada Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 19 Europe Immunotherapy Drugs Market, By Country, 2023-2030 (USD Billion)
Table 20 Europe Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 21 Europe Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 22 Europe Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 23 Europe Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 24 Germany Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 25 Germany Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 26 Germany Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 27 Germany Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 28 UK Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 29 UK Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 30 UK Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 31 UK Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 32 France Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 33 France Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 34 France Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 35 France Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 36 Italy Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 37 Italy Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 38 Italy Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 39 Italy Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 40 Spain Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 41 Spain Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 42 Spain Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 43 Spain Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 44 Rest of Europe Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 45 Rest of Europe Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 46 Rest of Europe Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 47 Rest of Europe Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 48 Asia Pacific Immunotherapy Drugs Market, By Country, 2023-2030 (USD Billion)
Table 49 Asia Pacific Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 50 Asia Pacific Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 51 Asia Pacific Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 52 Asia Pacific Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 53 China Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 54 China Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 55 China Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 56 China Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 57 India Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 58 India Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 59 India Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 60 India Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 61 Japan Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 62 Japan Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 63 Japan Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 64 Japan Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 65 South Korea Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 66 South Korea Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 67 South Korea Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 68 South Korea Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 69 Rest of Asia Pacific Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 70 Rest of Asia Pacific Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 71 Rest of Asia Pacific Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 72 Rest of Asia Pacific Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 73 Middle East and Africa Immunotherapy Drugs Market, By Country, 2023-2030 (USD Billion)
Table 74 Middle East and Africa Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 75 Middle East and Africa Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 76 Middle East and Africa Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 77 Middle East and Africa Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 78 GCC Countries Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 79 GCC Countries Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 80 GCC Countries Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 81 GCC Countries Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 82 South Africa Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 83 South Africa Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 84 South Africa Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 85 South Africa Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 86 Rest of Middle East and Africa Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 87 Rest of Middle East and Africa Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 88 Rest of Middle East and Africa Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 89 Rest of Middle East and Africa Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 90 Latin America Immunotherapy Drugs Market, By Country, 2023-2030 (USD Billion)
Table 91 Latin America Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 92 Latin America Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 93 Latin America Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 94 Latin America Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 95 Brazil Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 96 Brazil Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 97 Brazil Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 98 Brazil Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 99 Mexico Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 100 Mexico Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 101 Mexico Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 102 Mexico Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 103 Argentina Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 104 Argentina Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 105 Argentina Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 106 Argentina Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
Table 107 Rest of Latin America Immunotherapy Drugs Market, By Type, 2023-2030 (USD Billion)
Table 108 Rest of Latin America Immunotherapy Drugs Market, By Therapeutic Area, 2023-2030 (USD Billion)
Table 109 Rest of Latin America Immunotherapy Drugs Market, By Cancer Type, 2023-2030 (USD Billion)
Table 110 Rest of Latin America Immunotherapy Drugs Market, By End User, 2023-2030 (USD Billion)
List of Figures
Figure 1 Global Immunotherapy Drugs Market: Market Segmentation
Figure 2 Global Immunotherapy Drugs Market: Research Methodology
Figure 3 Breakdown of Primary Interviews
Figure 4 Top Down Approach
Figure 5 Bottom Up Approach
Figure 6 Data Triangulation
Figure 7 Global Immunotherapy Drugs Market: Drivers, Restraints, Opportunities, and Challenges
Figure 8 Global Immunotherapy Drugs Market: Porter’s Five Forces Model Analysis
Figure 9 Global Immunotherapy Drugs Market: Value Chain Analysis
Figure 10 Global Immunotherapy Drugs Market Share Analysis, By Type, 2023 and 2030
Figure 11 Global Immunotherapy Drugs Market Share Analysis, By Therapeutic Area, 2023 and 2030
Figure 12 Global Immunotherapy Drugs Market Share Analysis, By Cancer Type, 2023 and 2030
Figure 13 Global Immunotherapy Drugs Market Share Analysis, By End User, 2023 and 2030
Figure 14 Global Immunotherapy Drugs Market Share Analysis, By Region, 2023 and 2030
Figure 15 North America Immunotherapy Drugs Market Share Analysis, By Country, 2023 and 2030
Figure 16 North America Immunotherapy Drugs Market Share Analysis, By Type, 2023 and 2030
Figure 17 North America Immunotherapy Drugs Market Share Analysis, By Therapeutic Area, 2023 and 2030
Figure 18 North America Immunotherapy Drugs Market Share Analysis, By Cancer Type, 2023 and 2030
Figure 19 North America Immunotherapy Drugs Market Share Analysis, By End User, 2023 and 2030
Figure 20 Europe Immunotherapy Drugs Market Share Analysis, By Country, 2023 and 2030
Figure 21 Europe Immunotherapy Drugs Market Share Analysis, By Type, 2023 and 2030
Figure 22 Europe Immunotherapy Drugs Market Share Analysis, By Therapeutic Area, 2023 and 2030
Figure 23 Europe Immunotherapy Drugs Market Share Analysis, By Cancer Type, 2023 and 2030
Figure 24 Europe Immunotherapy Drugs Market Share Analysis, By End User, 2023 and 2030
Figure 25 Asia Pacific Immunotherapy Drugs Market Share Analysis, By Country, 2023 and 2030
Figure 26 Asia Pacific Immunotherapy Drugs Market Share Analysis, By Type, 2023 and 2030
Figure 27 Asia Pacific Immunotherapy Drugs Market Share Analysis, By Therapeutic Area, 2023 and 2030
Figure 28 Asia Pacific Immunotherapy Drugs Market Share Analysis, By Cancer Type, 2023 and 2030
Figure 29 Asia Pacific Immunotherapy Drugs Market Share Analysis, By End User, 2023 and 2030
Figure 30 Middle East and Africa Immunotherapy Drugs Market Share Analysis, By Type, 2023 and 2030
Figure 31 Middle East and Africa Immunotherapy Drugs Market Share Analysis, By Therapeutic Area, 2023 and 2030
Figure 32 Middle East and Africa Immunotherapy Drugs Market Share Analysis, By Cancer Type, 2023 and 2030
Figure 33 Middle East and Africa Immunotherapy Drugs Market Share Analysis, By End User, 2023 and 2030
Figure 34 Latin America Immunotherapy Drugs Market Share Analysis, By Type, 2023 and 2030
Figure 35 Latin America Immunotherapy Drugs Market Share Analysis, By Therapeutic Area, 2023 and 2030
Figure 36 Latin America Immunotherapy Drugs Market Share Analysis, By Cancer Type, 2023 and 2030
Figure 37 Latin America Immunotherapy Drugs Market Share Analysis, By End User, 2023 and 2030
Figure 38 Global Immunotherapy Drugs Market, By Competitive Benchmarking
Figure 39 Global Immunotherapy Drugs Market, By Vendor Share Analysis, 2023
PRICE
ASK FOR FREE SAMPLE REPORT